| 000 | 01408 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513105626.0 | ||
| 264 | 0 | _c19970107 | |
| 008 | 199701s 0 0 eng d | ||
| 022 | _a0002-9262 | ||
| 024 | 7 |
_a10.1093/oxfordjournals.aje.a008895 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBlais, L | |
| 245 | 0 | 0 |
_aConfounding by indication and channeling over time: the risks of beta 2-agonists. _h[electronic resource] |
| 260 |
_bAmerican journal of epidemiology _cDec 1996 |
||
| 300 |
_a1161-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAdrenergic beta-Agonists _xadverse effects |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAlbuterol _xadverse effects |
| 650 | 0 | 4 |
_aAsthma _xdrug therapy |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aConfounding Factors, Epidemiologic |
| 650 | 0 | 4 | _aEpidemiologic Methods |
| 650 | 0 | 4 |
_aFenoterol _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 700 | 1 | _aErnst, P | |
| 700 | 1 | _aSuissa, S | |
| 773 | 0 |
_tAmerican journal of epidemiology _gvol. 144 _gno. 12 _gp. 1161-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/oxfordjournals.aje.a008895 _zAvailable from publisher's website |
| 999 |
_c8948580 _d8948580 |
||